Literature DB >> 12769503

Bendectin and birth defects: hopefully, the final chapter.

Robert Brent1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12769503     DOI: 10.1002/bdra.10021

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


× No keyword cloud information.
  5 in total

Review 1.  Evaluation of the reproductive and developmental risks of caffeine.

Authors:  Robert L Brent; Mildred S Christian; Robert M Diener
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2011-03-02

Review 2.  Antihistamines and birth defects: a systematic review of the literature.

Authors:  Suzanne M Gilboa; Elizabeth C Ailes; Ramona P Rai; Jaynia A Anderson; Margaret A Honein
Journal:  Expert Opin Drug Saf       Date:  2014-10-11       Impact factor: 4.250

3.  Use of antihistamine medications during early pregnancy and isolated major malformations.

Authors:  Suzanne M Gilboa; Matthew J Strickland; Andrew F Olshan; Martha M Werler; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-02

4.  Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.

Authors:  Charlotte Gils; Anton Pottegård; Zandra Nymand Ennis; Per Damkier
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-17       Impact factor: 3.007

Review 5.  The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.

Authors:  Svetlana Madjunkova; Caroline Maltepe; Gideon Koren
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.